【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 13
1.2 List of Figures 13
2 Introduction 15
2.1 Report Scope 15
2.1.1 GlobalData Selection Criteria 16
2.1.2 Companies Covered 16
2.2 Upcoming Reports 17
2.3 Recently Published Reports 17
3 CRO Market Dynamics 18
3.1 Outsourcing Service Delivery Models 18
3.1.1 Fully Integrated Service Model 18
3.1.2 Functional Service Model 19
3.1.3 The Bottom Line: Use a Hybrid Approach 19
3.2 Quintiles Goes Public 20
3.2.1 Quintiles IPO Raises $947M, Pricing an Increased Number of Shares at Top Range 20
3.3 Weak Demand for Preclinical Services Causes CROs to Economize 20
3.4 CROs are Transitioning into Becoming Experts in Biologics Manufacturing 22
3.4.1 WuXi Will Become a Leader in Biologics Manufacturing through its Multi-pronged Strategy 23
3.4.2 Catalent Opens New Manufacturing Center for Biologic Drug Development 25
3.4.3 ShangPharma Inks Two mAb Partnerships 26
3.5 Emerging Locations in Asia Will See the Greatest Investment and Growth 27
3.5.1 Location, Location – Footprint Growth Has Become More Important than Cost Reduction 27
3.5.2 Will Concerns about Patient Safety Bring Down the Indian Clinical Trial Market? 29
3.6 eClinical Technologies Will be Key Drivers to Accelerating Time-to-Market 30
3.6.1 Icon and Cerner Team Up to Streamline Late-Phase Studies 31
3.6.2 Parexel Introduces MyTrials Platform 31
3.6.3 INC Research Expands Partnership with Medidata Solutions 32
3.6.4 Quintiles Unveils its Next-Generation Infosario Analytics Platform 33
3.6.5 Covance Launches Xcellerate to Increase Clinical Trial Optimization 33
4 Collaboration and Acquisition Strategies 34
4.1 Overview 34
4.2 M&A Analysis 38
4.2.1 KKR Makes a Splash into CRO Biz with PRA Buy 38
4.2.2 Quintiles Invests in Personalized Medicine 39
4.2.3 Patheon Completes Purchase of Banner Pharmacaps 39
4.2.4 Clinipace Doubles in Size with Paragon Buyout 40
4.2.5 Accenture Complements its R&D Service Offerings with Acquisition of Octagon 40
4.2.6 Catalent Pharma Buys Aptuit’s CTS Business 41
4.2.7 Charles River and Covance Expand Microbial Identification Capabilities 41
4.3 Strategic Partnerships with Large Pharmaceutical Clients 42
4.3.1 Quintiles and Merck Serono Announce Innovative Clinical Development Partnership 42
4.3.2 Charles River and AstraZeneca Align to Accelerate Drug Development 43
4.3.3 Covance Deals 43
4.3.4 Pfizer Improves Clinical Trial Flexibility with Icon and Parexel Partnership 44
4.3.5 Aptuit and GSK Extend Strategic Alliance 44
4.3.6 INC Research Enters into FSP Collaboration with Astellas 45
4.3.7 PRA Announces Strategic Biosimilar Development Agreement with Amgen 45
4.3.8 Parexel and Catalent Combine Core Competencies to Streamline Supply Chain 46
5 Regional Analysis 47
5.1 Overview 47
5.2 North America Landscape Assessment 50
5.2.1 Pharma’s Large Revenue Base in North America Continues to Drive CRO Sector Growth 50
5.3 Strategic Partnerships 52
5.3.1 Covance Collaborates with M2Gen and BioPontis Alliance 52
5.3.2 AMRI Signs Agreement to License its Novel Tubulin Inhibitor Program to Chai Therapeutics 53
5.3.3 Ockham Completes Acquisition of Nexus Oncology 54
5.3.4 Synteract and HCR Combine to Form Multinational CRO 54
5.3.5 Accelovance Buys Radiant’s CRO Division 55
5.3.6 Theorem Forms Relationship with IVD Consultancy Emergo Group 55
5.4 Operations and Global Service Delivery 57
5.4.1 AMRI Realigns its Drug Discovery Services 57
5.4.2 PPD and Icon Grow Bioassay Capabilities in the US 57
5.5 Revenue and Growth Leaders 59
5.5.1 Revenue 59
5.5.2 Revenue Growth YtY 61
5.6 Europe Landscape Assessment 62
5.6.1 European CRO Market Witnessed a Significant Pullback in Growth 62
5.7 Strategic Partnerships 64
5.7.1 TFS International Acquires Italian CRO Dimensione Ricerca 64
5.7.2 Quintiles Signs Deal to Bring Almirall’s LAMA Therapy to the UK 64
5.7.3 Icon Selected by European Pharma Companies as a Global Strategic Partner 65
5.7.4 CromSource Adds Early Phase Research Unit in Partnership with CRC 65
5.7.5 Covance Inks Tech Transfer Deal with France’s Inserm Transfert SA 66
5.8 Operations and Global Service Delivery 67
5.8.1 Patheon Invests in its SoluPath Program in the UK 67
5.8.2 Celerion Expands Belfast Facility with Containment Room for Biologics Studies 68
5.8.3 Harlan Labs Announces Major Investment in Switzerland 68
5.9 Revenue and Growth Leaders 70
5.9.1 Revenue 70
5.9.2 Revenue Growth YtY 72
5.10 Asia-Pacific Landscape Assessment 73
5.10.1 APAC Market Remains Hot for Clinical Outsourcing 73
5.11 Strategic Partnerships 76
5.11.1 Japanese CROs Grow their Domestic Footprints 76
5.11.2 AMRI Drives SmartSourcing Strategy in Japan 77
5.11.3 Covance-BML Boost Clinical Trial Lab in Japan 77
5.11.4 EPS Corporation Separates Business Units to Streamline Efficiency 78
5.11.5 Frontage Hired by Local Chinese Clients to Develop Drugs Overseas 78
5.11.6 DKSH Expands Services in South East Asia 79
5.12 Operations and Global Service Delivery 80
5.12.1 GVK BIO Selects New Distributor in Taiwan 80
5.12.2 Max Neeman International Grows Regional Footprint 80
5.12.3 ClinTec International 81
5.13 Revenue and Growth Leaders 81
5.13.1 Revenue 81
5.13.2 Revenue Growth YtY 83
5.14 Emerging Markets Landscape Assessment 84
5.14.1 BRICs and Other Emerging Regions Still Represent Huge Untapped Markets for R&D 84
5.15 Strategic Partnerships 86
5.15.1 Central and Latin America 86
5.15.2 Emerging EMEA 87
5.15.3 China 89
5.15.4 India 90
5.15.5 Rest of Asia 91
5.16 Operations and Global Service Delivery 94
5.16.1 Expand Strategic Investment in Emerging Markets to Support Business Growth 95
5.17 Revenue and Growth Leaders 99
5.17.1 Revenue 99
5.17.2 Revenue Growth YtY 100
5.17.3 Global Laboratory Accreditations and Certifications 101
6 Firm Utilization 103
6.1 Excerpt from CRO Benchmark Report: Heat Mapping 104
6.1.1 Covance Was the Firm Utilization Leader in 2012 104
6.2 Firm Utilization Metrics 105
6.2.1 Headcount Growth YtY 105
6.2.2 Revenue per Employee 106
6.2.3 Clinical Services Revenue per Clinical Services Employee 107
6.2.4 G&A Expense per G&A Employee 109
6.2.5 S&M Expense per S&M Employee 110
6.3 Human Capital Leadership Changes 111
6.3.1 Source Therapeutic and Regional Expertise to Boost Clinical Operations 111
6.4 Capital Management: Heat Map 113
6.4.1 EPS Was the Capital Management Leader in 2012 due to its Higher Liquidity 113
6.5 Capital Structure Metrics 114
6.5.1 Debt/Equity Ratio 114
6.5.2 Current Ratio 115
6.5.3 Cash Ratio 116
6.6 Share Offerings and Debt Restructurings 117
6.6.1 Proceeds from Share Repurchases Used to Pay-down Debt and Finance Acquisitions 117
7 Future Outlook 118
7.1 CRO Market 118
7.2 Vendor Positioning 120
8 Appendix 121
8.1 Research Methodology 121
8.1.1 Coverage 121
8.1.2 Secondary Research 121
8.2 About the Author 122
8.2.1 Adam Dion, Industry Analyst 122
8.3 Director, Healthcare Industry Dynamics 123
8.4 Global Head of Healthcare 123
8.5 About the Industry Dynamics Team 123
8.6 About GlobalData 124
8.7 Disclosure Information 124
8.8 Disclaimer 124
【レポート販売概要】
■ タイトル:PharmaSphere: Global Dealmaking and Operations Strategies in the CRO Market■ 英文:PharmaSphere: Global Dealmaking and Operations Strategies in the CRO Market
■ 発行日:2013年9月25日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162073
■ 調査対象地域:グローバル
- 世界における小児インターベンション心臓病(医療機械)市場動向及び予測(~2018)The global pediatric interventional cardiology market is a very dynamic market, as this market is witnessing a number of technological advancements, owing to which various new devices are being launched in the market. Traditionally, pediatric interventional cardiology was used for diagnostic purposes; however, currently, it is increasingly being used for treatment purposes as well. The transcathet …
- 業務用冷凍装置の世界市場:ディープフリーザー、ボトルクーラー、ストレージウォータークーラー、業務用キッチン冷凍、医療冷凍、チェスト冷凍Commercial refrigeration equipment are used for preserving food such as vegetables, fruits, meat, and other similar products, by maintaining a temperature of 30C to -40C and increasing the shelf life of the product. Relatively larger share of the market for refrigerators is expected to be accounted for in the near future due to replacement of existing equipment through energy efficient and sustain …
- MILES(レーザー交戦装置) の世界市場2016-2020About MILES MILES is a set of lasers and laser sensors, which is fastened on armed personnel, weapons, and vehicles to provide realistic training environment to the soldiers. During training, when soldiers fire at their opponents, it emits laser beams instead of ammunition. If the laser successfully hits a soldier, or sensor, or an opponent vehicle, the computer considers it as lethal and a signal …
- 冠動脈ステントのグローバル市場(2012-2018)Global Coronary Stents sector is projected to reach US$9.5 billion by 2016. The North America accounts for nearly 41% (2015) of the global value while Europe claims approximately 29% (2018). Asia-Pacific is the fastest growing region with a CAGR of 8.8% driving a market value of US$1.5 billion by 2015. On a global scale, projections for drug eluting stents market share indicate more than 40% by 20 …
- 食品容器の世界市場:プラスチック製容器、ガラス製容器、金属製容器About Food Containers The food industry is the largest of all industries in the world and plays an important role in the economy of any country. The global food and beverages market is expected to reach $5.77 trillion by 2017, growing at a CAGR of 5.02%. As food products need to be preserved for a long period, they are packaged in extremely protective and durable containers. An increased demand fo …
- Dental Caries:グローバル臨床試験レビューH1, 2013Dental Caries Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Dental Caries Global Clinical Trials Review, H1, 2013" provides data on the Dental Caries clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dental Caries. It includes an overview of the trial numbers and their recruitment status as per the …
- 世界の食品安全テスト市場展望(~2018)The problem of food being affected upon by several contaminants is becoming relevant worldwide, rising concerns for food safety testing. Pathogens, pesticides, toxins, etc. are some of the majorly found contaminants in the food items worldwide. They form a part of the food safety violations in almost every country across the globe. This has led various countries across the globe to adopt stringent …
- 油田向け通信ソリューションの世界市場予測(~2022年)“Increase in integration of departments in the oil and gas industry is driving the oilfield communications market”The oilfield communications market size is estimated to grow from USD 3.05 billion in 2017 to USD 4.46 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 7.9%. Integration of departments in the oil and gas industry and increasing significance of cyber security are some of the …
- グローバル建設産業の景況感レポート(H1 2015)• The report examines the prevailing economic conditions and executives opinion with regards to the global economy, and the state of the economy in various regions. • The report provides industry executives’ expectations on the growth prospects of their company and the industry as a whole over January–June 2015. • The report analyzes construction industry executives’ opinions on changes in custome …
- ヘルスケア/医療シミュレーション製品・サービスの世界市場予測(~2021年)The global medical simulation market is projected to reach USD 2.27 Billion by 2021, at a CAGR of 15.2% from 2016 to 2021. The market growth can be attributed to a number of factors such as increasing healthcare costs, rising focus on patient safety, and technological advancements. Increasing demand for minimally invasive treatments and increasing consolidation of the market players are other majo …
- 乗務員管理システムの世界市場予測(~2022年)The crew management system market is projected to grow from an estimated USD 1.31 Billion in 2016 to USD 2.35 Billion by 2022, at a CAGR of 10.19% from 2016 to 2022. Stringent regulations pertaining to working hours for crew members on board, safety of crew members and passengers are the major factors driving the crew management system market. Among systems, the on-cloud segment is expected to lea …
- 世界の燃料電池市場Fuel cells have become one of the fastest growing industries in recent years. From governments to private businesses and even academic institutions, all are collaborating to produce fuel cells and to find methods of improving their efficiency. Fuel cells have the capability to produce electrical power in an efficient and without causing any pollution. In the process, fuel cells also produce heat a …
- バイオセンサーの世界市場分析:、用途別(医療用、食品毒性検出、工程制御、農業、環境)、技術別(熱バイオセンサー、電気化学バイオセンサー、圧電バイオセンサー、光学バイオセンサー)、エンドユーザー別(家庭用ヘルスケア診断、ポイントオブケア検査、食品産業、研究所)、セグメント予測、-2020Global biosensors market is expected to reach USD 21.17 billion by 2020. Biosensors, owing to their capability to resolve various analytical issues in diverse areas such as medicine, pharmacology, food & agriculture safety and defense, are expected to witness a rapid growth in demand over the next six years. Increasing demand for specific detection techniques for early diagnosis in the healthcare …
- Mucopolysaccharidosis III (MPS III) (サンフィリッポ症候群):グローバル臨床試験動向(2014年上半期)Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Global Clinical Trials Review, H1, 2014" provides data on the Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) clinical trial scenario. This report provides elemental information and data re …
- 2014年戦略提言:イタリアの臨床化学・免疫診断市場Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.“2014 Strategies for the Italian Clinical Chemistry and Immunodiagnostic Market” is a new strategic analysis of major business opportunities emerging in the Italian clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the …